For the Inventor, By the Inventor

Enter assignee name

Copenhagen, Denmark

Statens Serum Institut

USPTO Granted Patents = 53

CIPO Patents = 9

EPO Patents = 26

Trademarks = 7

Forward Citations = 414

Loading Chart...

Loading Chart...

87 inventors (with patents filed for the assignee):

Peter Andersen (26 out of 28 patents)

Claus Aagaard (10 out of 10 patents)

Ida Rosenkrands (9 out of 9 patents)

4. Inga Laursen (6 out of 6 patents)

5. Jes Dietrich (5 out of 5 patents)

6. Anders Fomsgaard (5 out of 5 patents)

7. Anja Olsen (4 out of 4 patents)

8. Carina Vingsbo-Lundberg (4 out of 4 patents)

9. Karin Weldingh (4 out of 4 patents)

10. Peter Birk Rasmussen (4 out of 10 patents)

11. Else Marie Agger (3 out of 3 patents)

12. Gunnar Houen (3 out of 3 patents)

13. Rikke Louise Vinther Skjot (3 out of 3 patents)

14. Walter Florio (3 out of 3 patents)

15. Frank Follmann (2 out of 2 patents)

Core Competencies:

Noninvasive Molecular Clock

Polygene Influenza Vaccine

Tuberculosis Vaccines

Alpha-Tocopherol Adjuvant

Diagnostic Reagents

Therapeutic TB Vaccine

Influenza Vaccine Optimization

Adjuvant Combinations

Nanofiltration Methods

Malaria Vaccine

Immunoglobulin Production

M. Tuberculosis Antigens

53 patents: Sort by Forward Citations

1. 12444478 - Noninvasive molecular clock for fetal development predicts gestational age and preterm delivery (2025-10-14),

2. 11389525 - Polygene influenza vaccine (2022-07-19),

3. 10925954 - Vaccines againstsp (2021-02-23),

4. 10786579 - Skin testing for tuberculosis in immunocompromised persons (2020-09-29),

5. 10729765 - Alpha-tocopherol-based adjuvanted solvent for DNA vaccines (2020-08-04),

6. 10641770 - Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis (2020-05-05),

7. 10519202 - Tuberculosis TB vaccine to prevent reactivation (2019-12-31),

8. 10004793 - M.tuberculosis vaccines (2018-06-26),

9. RE46583 - Vaccines comprising TB10.4 (2017-10-23),

10. 9764024 - Optimized influenza vaccines (2017-09-19),

11. 9526773 - [object Object] (2016-12-27),

12. 9523131 - PCR diagnostics of dermatophytes and other pathogenic fungi (2016-12-20),

13. 9410960 - Method of diagnosing galactosemia in neonatal screening (2016-08-09),

14. 9279160 - [object Object] (2016-03-08),

15. 9140691 - Diagnostic blood test using adsorption on filter paper (2015-09-22),

Statens Serum Institut (SSI) is a Danish organization responsible for controlling and preventing infectious diseases, biological threats, and congenital disorders. With a mission to enhance the health and welfare of Danish society, SSI conducts research, surveillance, and diagnoses of diseases, while also producing vaccines, biological products, and other biological materials. They collaborate with national and international partners, providing expertise and guidance in the field of infectious diseases and public health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

53 Patents

#7 in

#60 in

#12,953 in the World

Copenhagen, Denmark

Statens Serum Institut

Forward Citations = 414

87 inventors:

Peter Andersen (26 out of 28 patents)

Claus Aagaard (10 out of 10 patents)

Ida Rosenkrands (9 out of 9 patents)

4. Inga Laursen (6 out of 6 patents)

5. Jes Dietrich (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…